Ysios Capital Partners takes part in Kala Pharmaceuticals' closing of $68 Million Series C Financing

by Ysios Capital

Kala was founded by leaders in the fields of nanomedicine and biopharmaceutical engineering, and is backed by leading life sciences investors including Longitude Capital, OrbiMed, Vivo Capital, CAM Ca...

Read more
Subscribe to Directory
Write an Article

Highlight

3i closes second European CLO, Harvest V...

by 3i Group

3i Group plc (“3i” or “3i Group”), an international investor, ...

Inkemia pondrá en marcha un fondo de oc...

by InKemia IUCT group

La compañía quiere invertir en 24 empresas españolas en los próxim...

Photos Stream